Inuvo Launches Ranger: AI Tool for Ad Quality and Compliance LITTLE ROCK, Ark., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced the launch of Ranger, an advanced quality assurance and compliance feature within its Campsight system. Campsight is Inuvo’s integrated environment for managing content, campaigns, and regulatory oversight. Ranger is designed to verify that every ad creative is accurate, relevant, and consistent with the page a user sees after clicking the ad. This ensures higher...
A director at Opko Health Inc bought 580,000 shares at 1.326USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Wednesday, December 3rd at 12:00 p.m. Eastern time. Investors interested in scheduling a meeting with OPKO management should conta...
Inuvo Introduces IntentPath for Next-Level Audience Visualization LITTLE ROCK, Ark., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced enhancements to the IntentKey® Platform, marking a major advancement in the way marketers create, visualize, understand, and activate audiences based on intent. The updated platform introduces IntentPath, a new visualization capability that predicts how audiences move from awareness to engagement to conversion. Inuvo’s proprietary large language model maps h...
LeMaitre to Participate in Upcoming Investor Conferences BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, November 18, 2025Waldorf Hilton, LondonDorian LeBlanc, CFO, will present at 8:00 AM GMT Wolfe Research 7th Annual Healthcare Conference Wednesday, November 19, 2025Wolfe NYC Offices, New York, NYDavid Roberts, President, will present at 10:40 AM ET Piper Sandler 37th Annual Healthcare Conference Th...
Collegium to Participate in Upcoming Investor Conferences STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies London Healthcare ConferencePresentation Date and Time: Wednesday, November 19, 2025, at 8:00 a.m. GMTLondon, UK The presentation will be webcast live and can be accessed from the Investors section of the Company's website: . A replay of the webcast will be archived on the Company's website for 90 days following the presentation. Piper Sandler 37th Annual Health...
A director at Collegium Pharmaceutical Inc sold 30,000 shares at 40.525USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Inuvo Reports Revenue of $22.6 Million in the Third Quarter 2025 Management to host conference call at 4:15 PM ET, Thursday, November 6, 2025 LITTLE ROCK, Ark., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, announced today its financial results for the third quarter and nine-month period ended September 30, 2025. Third Quarter 2025 Highlights Compared to Third Quarter 2024: 23 new clients onboarded in Q3Net revenue increased 1% to $22.6 million from $22.4 millionGross margin decreased to 73.4% from ...
LeMaitre Q3 2025 Financial Results BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q3 2025 results include a non-recurring benefit from the Employee Retention Tax Credit. Non-GAAP adjusted figures exclude this benefit. A reconciliation of GAAP to non-GAAP results is included. Q3 2025: Sales $61.0mm, +11% (+12% organic)Gross margin 75.3% (+750 bps), adjusted 70.8% (+300 bps)Op. income $2...
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance – Generated Record Quarterly Net Revenue of $209.4 Million, Up 31% Year-over-Year – – Generated Record Quarterly Jornay PM® Net Revenue of $41.8 Million; Grew Prescriptions by 20% Year-over-Year – – Generated Record Quarterly Pain Portfolio Net Revenue of $167.6 Million, Up 11% Year-over-Year, with All Three Core Products Growing Year-over-Year – – Raised Full-Year 2025 Net Revenue Guidance to be in the Range of $775 to $785 Million and Adjusted EBITDA Guidance in the Range of $460 to $470 Million – – Ended Q3...
Angi Inc. Earnings Release and Letter to Shareholders Available on Company’s Website DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) posted its third quarter financial results and a letter to shareholders from CEO, Jeffrey Kip on the investor relations section of its website at ir.angi.com/quarterly-earnings. As announced previously, Angi Inc. will host a conference call to discuss the company’s third quarter results and to answer questions. The call will be held on Wednesday, November 5, 2025, at 8:30 a.m. ET. Jeffrey Kip, CEO and Andrew Russakoff, CFO will participate...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.